FOLEY & LARDNER LLP

Lobbying for COHERUS BIOSCIENCES · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Government Issues

Issues related to federal drug reimbursement and domestic manufacturing policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem